- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gerard Anderson Explains the Benefits of Healthcare Systems in Germany and the UK
The healthcare systems in Germany and the United Kingdom are examples of systems that are able to manage costs while improving access to medications; however, it is unlikely that the US will follow these models, explained Gerard Anderson, PhD, of Johns Hopkins Bloomberg School of Public Health.
Transcript (slightly modified)
What is being done in other countries to improve access to medications? Can the US use these as a model?
There are a lot of things that we could do, but very few things that we probably will do. There are 2 systems that we really should take a look at very closely. The first one is in the UK and it’s called NICE, and the second one is in Germany—they’re similar, but different.
The easiest one to understand is NICE in the UK, and what they do is they say if a drug, or if a device, costs more than about $40,000 per quality-adjusted life year—a poor life year, to make it a little simpler—they will pay for it. If you charge more than that, we’re not going to buy it. Now a drug company knows, "well, if I price it at $39,999, I’m going to get it covered, and if I price it at $50,000, I’m not going to get it covered." So, you’ve told them exactly what they’re going to do.
Germany does something very similar to that, but not exactly the same. It makes some more adjustments for the type of disease that you have. It essentially says if you have cancer, or something like that, we might pay a little bit more than if you have diabetes. It’s all based upon, historically, how much we spend for that particular drug to treat you.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
